NEW YORK, Jan. 11, 2011 /PRNewswire-USNewswire/ -- Peter Quinn, CEO of the T.J. Martell Foundation, is pleased to announce the 2011 cancer and AIDS research grant recipients.
Martell-funded research at Massachusetts General Hospital Cancer Center made national headlines this week when it was announced that health care giant Johnson & Johnson is helping to bring this revolutionary blood test to market.
In addition to the continuation of innovative cancer and AIDS research the Foundation funds at several leading hospitals nationwide, the Foundation will also begin contributing to research at MD Anderson Cancer Center in Houston, Texas. "We are excited to begin funding a new program to involve oncology fellows in specialized research projects at the MD Anderson Cancer Center, something which we hope to grow in the future. Supporting young investigators and growing the next generation of leaders in cancer research has always been one of the priorities of the Foundation," says Scientific Advisory Committee Chairman Dr. Gregory Curt.
The Foundation is a longtime donor to breast cancer and leukemia research at T.J. Martell Memorial Laboratories at Mt. Sinai Medical Center; pediatric cancer and leukemia research at Children's Hospital Los Angeles; lung, colon, prostate, breast and ovarian cancer research at Vanderbilt-Ingram Cancer Center; psycho-oncology research at Memorial Sloan-Kettering Cancer Center; and prostate cancer research at Columbia-Presbyterian Cancer Center and The Mayo Clinic.
Detailed descriptions of each research project can be found on the Foundation's website. Every fall, the T.J. Martell Scientific Advisory Committee reviews applications from research laboratories to determine which studies will receive funding. All grants are awarded based on scientific merit, and help to support experimental research that might not otherwise receive funding.
ABOUT THE T.J. MARTELL FOUNDATION
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research was founded in 1975 by music industry executive Tony Martell and his colleagues, in loving memory of his son, T.J., who died of leukemia. Since then the Foundation has provided over $250 million dollars for research.
CONTACT: Kate Fitzpatrick, 212-833-5444
SOURCE T.J. Martell Foundation